会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD OF ADMINISTERING LIPOSOMES CONTAINING OLIGONUCLEOTIDES
    • 含有寡核苷酸的脂质体的施用方法
    • WO2007014150A2
    • 2007-02-01
    • PCT/US2006/028658
    • 2006-07-24
    • NEOPHARM, INC.SHERMAN, JeffreyPARKER, KristenAHMAD, Imran
    • SHERMAN, JeffreyPARKER, KristenAHMAD, Imran
    • A61K48/00
    • A61K48/0008A61K9/1272C12N15/1135C12N2310/11
    • The invention provides a method of treating a cellular proliferative disease, a method of inhibiting the growth of neoplastic cells and a method of reducing the expression of a raf sequence by administering an effective amount of a cationic liposomal composition. The cationic liposomal composition comprises c-raf Antisense Oligonucleotide (c-rafAON), a cationic cardiolipin analogue and, desirably, another lipid species. The preferred cationic cardiolipin analogue is l,3-Bis-(l,2-bis-tetradecyloxy-propyl-3- dimethylethoxyammoniumbromide)-propane-2-ol (PCL-2). The preferred lipids include cholesterol, dioleoylphosphatidylethanolamine (DOPE), 1,2 Dioleoyl-sn-glycero-3- phosphocholine (DOPC), alpha tocopheryl acid succinate and phosphatidylcholine. The effective amount of the cationic liposomal composition is about 60 mg/m 2 .
    • 本发明提供了治疗细胞增殖性疾病的方法,抑制肿瘤细胞生长的方法和通过施用有效量的阳离子脂质体组合物来降低raf序列的表达的方法。 阳离子脂质体组合物包含c-raf反义寡核苷酸(c-rafAON),阳离子心磷脂类似物,并且理想地是另一种脂质物质。 优选的阳离子心磷脂类似物是1,3-双 - (1,2-双 - 十四烷氧基 - 丙基-3-二甲基乙氧基溴化铵) - 丙-2-醇(PCL-2)。 优选的脂质包括胆固醇,二油酰磷脂酰乙醇胺(DOPE),1,2-二油酰-sn-甘油-3-磷酸胆碱(DOPC),α-生育酚酸琥珀酸酯和磷脂酰胆碱。 阳离子脂质体组合物的有效量为约60mg / m 2。
    • 2. 发明申请
    • SYNTHESIS OF CARDIOLIPIN ANALOGUES AND USES THEREOF
    • 卡培他滨类似物的合成及其用途
    • WO2006052906A2
    • 2006-05-18
    • PCT/US2005/040325
    • 2005-11-08
    • NEOPHARM, INC.AHMAD, Moghis, U.UKKALAM, Murali, K.ALI, Shoukath, M.AHMAD, Imran
    • AHMAD, Moghis, U.UKKALAM, Murali, K.ALI, Shoukath, M.AHMAD, Imran
    • A61K31/663
    • C07F9/106
    • The invention provides novel synthetic methodologies for preparing cardiolipin, migrated caridiolipin (1,2-positional isomer of cardiolipin) and their analogues having varying fatty acids and/or alkyl chains with varying length and degrees of saturation/unsaturation. The method comprises (a) reacting an optically pure 1,2- O -dialkyl- sn -glycerol or 1,2- O -dialkyl- sn -glycerol with one or more phosphoramidite reagent(s), wherein a phosphite triester is produced; (b) coupling the product of (a) with glycerol, wherein a protected cardiolipin is produced; and (c) deprotecting the protected cardiolipin, such that cardiolipin is prepared. The cardiolipins and analogues thereof, prepared by the present methods, can be incorporated into liposomes, which can also include active agents such as hydrophobic or hydrophilic drugs, antisense nucleotides or diagnostic agents. Such liposomes can be used to treat diseases or can be used in diagnostic and/or analytical assays.
    • 本发明提供了新的合成方法,用于制备心磷脂,迁移的卡立二磷(心磷脂的1,2位异构体)及其类似物,其具有不同长度和饱和度/不饱和度变化的脂肪酸和/或烷基链。 该方法包括(a)使光学纯的1,2-O-二烷基-sn-甘油或1,2-二烷基-sn-甘油与一种或多种亚磷酰胺试剂反应,其中产生亚磷酸三酯; (b)将(a)的产物与甘油偶联,其中产生受保护的心磷脂; 和(c)使保护的心磷脂脱保护,使得制备心磷脂。 通过本发明方法制备的心磷脂及其类似物可以掺入脂质体中,脂质体还可以包括活性剂如疏水或亲水药物,反义核苷酸或诊断剂。 这样的脂质体可用于治疗疾病或可用于诊断和/或分析测定。